12 Week,Comparing Safety of HMR1964 & Insulin Aspart Used in Continuous Subcutaneous Infusion in Type 1 Diabetes.
The purpose of this study is to compare the safety of HMR 1964 and insulin aspart when used
in external pumps with respect to catheter occlusions, GHb assessment, insulin doses, blood
glucose parameters, hypoglycemic episodes, unexplained hyperglycemia, adverse events,
laboratory data, and vital signs.
Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes
Novo Nordisk A/S
This trial is conducted in the United States of America (USA). The purpose of this study is
to test whether NovoLog (insulin aspart) is a safe and at least as effective alternative to
regular human insulin for the control of blood glucose after meals in women who develop
diabetes during pregnancy.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.